Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer
- 1 December 1988
- journal article
- clinical trial
- Published by Springer Nature in British Journal of Cancer
- Vol. 57 (6), 608-611
- https://doi.org/10.1038/bjc.1988.138
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- IMMUNOCYTOCHEMICAL DEMONSTRATION OF ESTROGEN-RECEPTORS BY MONOCLONAL-ANTIBODIES IN HUMAN-BREAST CANCER - CORRELATION WITH ESTROGEN-RECEPTOR ASSAY BY DEXTRAN-COATED CHARCOAL METHOD1987
- Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cellsCell, 1987
- Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptorBiochemical and Biophysical Research Communications, 1986
- Triphenylethylenes: A New Class of Protein Kinase C InhibitorsJNCI Journal of the National Cancer Institute, 1986
- Effects of the antioestrogen tamoxifen on the cell cycle kinetics of the human breast cancer cell line, MCF-7British Journal of Cancer, 1984
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984
- British Interlaboratory Quality Assessment of Steroid Receptor AssaysPublished by Springer Nature ,1984
- CELL-PROLIFERATION KINETICS OF MCF-7 HUMAN MAMMARY-CARCINOMA CELLS IN CULTURE AND EFFECTS OF TAMOXIFEN ON EXPONENTIALLY GROWING AND PLATEAU-PHASE CELLS1983
- Measurement of oestradiol receptors by five institutions on common tissue samplesBritish Journal of Cancer, 1978